The role of the cutaneous microbiome in skin cancer: lessons learned from the gut

J Drugs Dermatol. 2015 May;14(5):461-5.

Abstract

The human microbiome has recently gained prominence as a major factor in health and disease. Here we review the literature regarding the microbiome and cancer and suggest how the microbiome may be manipulated for improved health outcomes. The gut microbiome has been relatively well studied, and the mechanisms of how it may increase or decrease the risk of certain cancers may apply to the skin microbiome. Additionally, the gut microbiome may directly impact the risk of cancer in the skin and other organs by promoting systemic inflammation. The skin microbiome itself is as diverse as the gut microbiome, but research has just begun to unravel its influence on the host. Like the gut microbiome, it affects the risk for several diseases, including cancer. By using healthpromoting strains from the microbiome in oral or topical probiotics, it may be possible to reduce the risk of skin cancer and perhaps even increase the likelihood of successful treatment.

Publication types

  • Review

MeSH terms

  • Animals
  • Gastrointestinal Tract / microbiology
  • Humans
  • Inflammation / microbiology
  • Inflammation / pathology
  • Microbiota*
  • Probiotics / administration & dosage
  • Skin / microbiology*
  • Skin / pathology
  • Skin Neoplasms / microbiology*
  • Skin Neoplasms / pathology